176 related articles for article (PubMed ID: 26083364)
1. Monitoring HIV Drug Resistance Early Warning Indicators in Cameroon: A Study Following the Revised World Health Organization Recommendations.
Fokam J; Elat JB; Billong SC; Kembou E; Nkwescheu AS; Obam NM; Essiane A; Torimiro JN; Ekanmian GK; Ndjolo A; Shiro KS; Bissek AC
PLoS One; 2015; 10(6):e0129210. PubMed ID: 26083364
[TBL] [Abstract][Full Text] [Related]
2. Programme quality indicators of HIV drug resistance among adolescents in urban versus rural settings of the centre region of Cameroon.
Fokam J; Nangmo A; Wandum C; Takou D; Santoro MM; Nlend AN; Ateba FN; Ndombo PK; Kamgaing N; Kamta C; Essiane A; Lambo V; Fokunang C; Mbanya D; Colizzi V; Perno CF; Ndjolo A
AIDS Res Ther; 2020 May; 17(1):14. PubMed ID: 32398107
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the World Health Organization's HIV Drug Resistance Early Warning Indicators in Main and Decentralized Outreach Antiretroviral Therapy Sites in Namibia.
Mutenda N; Bukowski A; Nitschke AM; Nakanyala T; Hamunime N; Mekonen T; Tjituka F; Mazibuko G; Mwinga S; Mabirizi D; Sagwa E; Indongo R; Dean N; Jordan MR; Hong SY
PLoS One; 2016; 11(12):e0166649. PubMed ID: 27906995
[TBL] [Abstract][Full Text] [Related]
4. Population-based monitoring of HIV drug resistance early warning indicators in Uganda: A nationally representative survey following revised WHO recommendations.
Asio J; Watera C; Namuwenge N; Kirungi W; Musinguzi J; Mugagga K; Busobozi R; Tusiime BJ; Lutalo T; Mbidde EK; Kaleebu P;
PLoS One; 2020; 15(4):e0230451. PubMed ID: 32287264
[TBL] [Abstract][Full Text] [Related]
5. Alarming rates of virological failure and HIV-1 drug resistance amongst adolescents living with perinatal HIV in both urban and rural settings: evidence from the EDCTP READY-study in Cameroon.
Fokam J; Takou D; Njume D; Pabo W; Santoro MM; Njom Nlend AE; Beloumou G; Sosso S; Moudourou S; Teto G; Dambaya B; Djupsa S; Tetang Ndiang S; Ateba FN; Billong SC; Kamta C; Bala L; Lambo V; Tala V; Chenwi Ambe C; Mpouel ML; Cappelli G; Cham F; Ndip R; Mbuagbaw L; Koki Ndombo P; Ceccherini-Silberstein F; Colizzi V; Perno CF; Ndjolo A
HIV Med; 2021 Aug; 22(7):567-580. PubMed ID: 33792134
[TBL] [Abstract][Full Text] [Related]
6. HIV drug resistance early warning indicators in namibia with updated World Health Organization guidance.
Jonas A; Sumbi V; Mwinga S; DeKlerk M; Tjituka F; Penney S; Jordan MR; Desta T; Tang AM; Hong SY
PLoS One; 2014; 9(7):e100539. PubMed ID: 24988387
[TBL] [Abstract][Full Text] [Related]
7. Early warning indicators for HIV drug resistance in Cameroon during the year 2010.
Billong SC; Fokam J; Nkwescheu AS; Kembou E; Milenge P; Tsomo Z; Dion GN; Aghokeng AF; Mpoudi EN; Ndumbe PM; Colizzi V; Elat Nfetam JB
PLoS One; 2012; 7(5):e36777. PubMed ID: 22615810
[TBL] [Abstract][Full Text] [Related]
8. [National profile of early warning indicators of HIV pharmaco-resistance in Cameroon].
Billong SC; Fokam J; Penda CI; Mvilongo EA; Fodjo R; Messeh A; Anoubissie JD; Kegne C; Nguekam G; Batamack YA; Billong EJ; Moutapam PR; Ndjolo A; Bonono L; Elat JB; Bissek ACZ
Pan Afr Med J; 2020; 37():374. PubMed ID: 33796187
[TBL] [Abstract][Full Text] [Related]
9. Declining trends in early warning indicators for HIV drug resistance in Cameroon from 2008-2010: lessons and challenges for low-resource settings.
Fokam J; Billong SC; Bissek AC; Kembou E; Milenge P; Abessouguie I; Nkwescheu AS; Tsomo Z; Aghokeng AF; Ngute GD; Ndumbe PM; Colizzi V; Elat JB
BMC Public Health; 2013 Apr; 13():308. PubMed ID: 23565992
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of treatment response, drug resistance and HIV-1 variability among adolescents on first- and second-line antiretroviral therapy: a study protocol for a prospective observational study in the centre region of Cameroon (EDCTP READY-study).
Fokam J; Santoro MM; Takou D; Njom-Nlend AE; Ndombo PK; Kamgaing N; Kamta C; Essiane A; Sosso SM; Ndjolo A; Colizzi V; Perno CF
BMC Pediatr; 2019 Jul; 19(1):226. PubMed ID: 31277610
[TBL] [Abstract][Full Text] [Related]
11. Predictors of poor retention on antiretroviral therapy as a major HIV drug resistance early warning indicator in Cameroon: results from a nationwide systematic random sampling.
Billong SC; Fokam J; Penda CI; Amadou S; Kob DS; Billong EJ; Colizzi V; Ndjolo A; Bisseck AZ; Elat JN
BMC Infect Dis; 2016 Nov; 16(1):678. PubMed ID: 27846809
[TBL] [Abstract][Full Text] [Related]
12. Population-based monitoring of emerging HIV-1 drug resistance on antiretroviral therapy and associated factors in a sentinel site in Cameroon: low levels of resistance but poor programmatic performance.
Billong SC; Fokam J; Aghokeng AF; Milenge P; Kembou E; Abessouguie I; Meva'a-Onglene FB; Bissek AC; Colizzi V; Mpoudi EN; Elat JB; Shiro KS
PLoS One; 2013; 8(8):e72680. PubMed ID: 23991142
[TBL] [Abstract][Full Text] [Related]
13. HIV drug resistance early warning indicators in Namibia for public health action.
Jonas A; Gweshe J; Siboleka M; Deklerk M; Gawanab M; Badi A; Sumbi V; Pereko D; Blom A; Mwinga S; Jordan MR; Jerger L; Lau K; Hong SY
PLoS One; 2013; 8(6):e65653. PubMed ID: 23762406
[TBL] [Abstract][Full Text] [Related]
14. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.
Jordan MR; Bennett DE; Bertagnolio S; Gilks CF; Sutherland D
Antivir Ther; 2008; 13 Suppl 2():15-23. PubMed ID: 18575188
[TBL] [Abstract][Full Text] [Related]
15. HIV drug-resistance early-warning indicators and quality care in India: preliminary findings from a pilot study in Pune city.
Ghate M; Kadam D; Gaikwad N; Shankar S; Gurav S; Rahane G; Tanwar S; Rewari B; Gangakhedkar R
WHO South East Asia J Public Health; 2015; 4(2):123-129. PubMed ID: 28607310
[TBL] [Abstract][Full Text] [Related]
16. Early warning indicators for HIV drug resistance in adults in South Africa at 2 pilot sites, 2008-2010.
Dube NM; Tint KS; Summers RS
Clin Infect Dis; 2014 Jun; 58(11):1607-14. PubMed ID: 24585566
[TBL] [Abstract][Full Text] [Related]
17. Challenges to and opportunities for the adoption and routine use of early warning indicators to monitor pediatric HIV drug resistance in Kenya.
Pilgrim NA; Okal J; Matheka J; Mukui I; Kalibala S
BMC Pediatr; 2018 Jul; 18(1):243. PubMed ID: 30045700
[TBL] [Abstract][Full Text] [Related]
18. Pre-treatment drug resistance and HIV-1 genetic diversity in the rural and urban settings of Northwest-Cameroon.
Fokam J; Takou D; Teto G; Nforbih SE; Kome OP; Santoro MM; Ngoufack ES; Eyongetah M; Palmer D; Fokunang ET; Fokunang CN; Colizzi V; Perno CF; Ndjolo A
PLoS One; 2020; 15(7):e0235958. PubMed ID: 32692778
[TBL] [Abstract][Full Text] [Related]
19. An assessment of the relationship between the World Health Organization HIV drug resistance early warning indicators and HIV drug resistance acquisition.
St-Jean M; Harrigan PR; Sereda P; Montaner J; Lima VD
HIV Med; 2017 May; 18(5):342-353. PubMed ID: 27704659
[TBL] [Abstract][Full Text] [Related]
20. Early warning indicators for population-based monitoring of HIV drug resistance in 6 African countries.
Sigaloff KC; Hamers RL; Menke J; Labib M; Siwale M; Ive P; Botes ME; Kityo C; Mandaliya K; Wellington M; Osibogun A; Geskus RB; Stevens WS; van Vugt M; Rinke de Wit TF;
Clin Infect Dis; 2012 May; 54 Suppl 4():S294-9. PubMed ID: 22544190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
